About company
Bast Biotechnology has developed innovative technology to fight fibrotic disease. The intial indication will target non-alcolic fibrotic liver disease (NAFLD) and non-alcoholic steatosis hepatitis (NASH).
- US
- [email protected]
- Unknown
- www.bastbiotech.com/
- Not verified company
